fmm.... total Zenith sale in a perfect world would be the best scenario. However, Zenith's finger is in too many collaborative pies and that may be a position that may take some time to unwind. You just can't simply abandon what is in play in fairness after all it has not cost Zenith any money for the many clinical calibrations that are ongoing. The best we can hope for is for one of the collaborative efforts to bear fruit and we're on our way to an IPO with a NASDAQ listing. I can't see any other outcome with what we have to deal with at present.

IMO ... Koo